Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells.
Saved in:
| Title: | Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells. |
|---|---|
| Authors: | Boutier H; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Kogler J; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany., Loureiro LR; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Neuber C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Berndt N; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Arndt C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Mildred Scheel Early Career Center, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Stadlbauer S; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany., Stephan H; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Feldmann A; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany., Kopka K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany., Hagemeyer CE; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Bachmann M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany. |
| Source: | Oncoimmunology [Oncoimmunology] 2025 Dec 31; Vol. 14 (1), pp. 2598908. Date of Electronic Publication: 2025 Dec 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41395806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boutier+H%22">Boutier H</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kogler+J%22">Kogler J</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Loureiro+LR%22">Loureiro LR</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Neuber+C%22">Neuber C</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Berndt+N%22">Berndt N</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Arndt+C%22">Arndt C</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Mildred Scheel Early Career Center, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Stadlbauer+S%22">Stadlbauer S</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Stephan+H%22">Stephan H</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Feldmann+A%22">Feldmann A</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.<br /><searchLink fieldCode="AU" term="%22Kopka+K%22">Kopka K</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.<br /><searchLink fieldCode="AU" term="%22Hagemeyer+CE%22">Hagemeyer CE</searchLink>; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Bachmann+M%22">Bachmann M</searchLink>; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology & Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2025 Dec 31; Vol. 14 (1), pp. 2598908. <i>Date of Electronic Publication: </i>2025 Dec 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41395806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2025.2598908 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2598908 Titles: – TitleFull: Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boutier H – PersonEntity: Name: NameFull: Kogler J – PersonEntity: Name: NameFull: Loureiro LR – PersonEntity: Name: NameFull: Neuber C – PersonEntity: Name: NameFull: Berndt N – PersonEntity: Name: NameFull: Arndt C – PersonEntity: Name: NameFull: Stadlbauer S – PersonEntity: Name: NameFull: Stephan H – PersonEntity: Name: NameFull: Feldmann A – PersonEntity: Name: NameFull: Kopka K – PersonEntity: Name: NameFull: Hagemeyer CE – PersonEntity: Name: NameFull: Bachmann M IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 12 Text: 2025 Dec 31 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2162-402X Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |